Respiratory syncytial virus infection in infants with heart and lung diseases

Hiroyuki Yamagishi

doi:10.1007/978-981-15-1185-1_31

Respiratory syncytial virus infection in infants with heart and lung diseases

Hiroyuki Yamagishi

Department of Pediatrics

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Respiratory syncytial virus (RSV) is a major causative agent of respiratory infection in infants because of its affinity for bronchial and alveolar epithelial cells. Serious and sometimes fatal RSV infection may develop in premature infants as well as infants with chronic lung disease and congenital heart disease (CHD). In infants with CHD, the addition of RSV infection to the underlying respiratory pathology resulting from increase or decrease in pulmonary blood flow may cause significant problems such as serious symptoms, increases in hospitalization rate, postponement of elective heart surgery, or death. Strict infection control measures with administration of anti-RSV antibody are essential in the management of infants with heart and lung diseases.

Original language	English
Title of host publication	Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension
Publisher	Springer Singapore
Pages	215-220
Number of pages	6
ISBN (Electronic)	9789811511851
ISBN (Print)	9789811511844
DOIs	https://doi.org/10.1007/978-981-15-1185-1_31
Publication status	Published - 2020 Jan 1

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-981-15-1185-1_31

Cite this

@inbook{865290b1f07340dd82c121487b69d195,

title = "Respiratory syncytial virus infection in infants with heart and lung diseases",

abstract = "Respiratory syncytial virus (RSV) is a major causative agent of respiratory infection in infants because of its affinity for bronchial and alveolar epithelial cells. Serious and sometimes fatal RSV infection may develop in premature infants as well as infants with chronic lung disease and congenital heart disease (CHD). In infants with CHD, the addition of RSV infection to the underlying respiratory pathology resulting from increase or decrease in pulmonary blood flow may cause significant problems such as serious symptoms, increases in hospitalization rate, postponement of elective heart surgery, or death. Strict infection control measures with administration of anti-RSV antibody are essential in the management of infants with heart and lung diseases.",

author = "Hiroyuki Yamagishi",

year = "2020",

month = jan,

day = "1",

doi = "10.1007/978-981-15-1185-1_31",

language = "English",

isbn = "9789811511844",

pages = "215--220",

booktitle = "Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension",

publisher = "Springer Singapore",

}

TY - CHAP

T1 - Respiratory syncytial virus infection in infants with heart and lung diseases

AU - Yamagishi, Hiroyuki

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Respiratory syncytial virus (RSV) is a major causative agent of respiratory infection in infants because of its affinity for bronchial and alveolar epithelial cells. Serious and sometimes fatal RSV infection may develop in premature infants as well as infants with chronic lung disease and congenital heart disease (CHD). In infants with CHD, the addition of RSV infection to the underlying respiratory pathology resulting from increase or decrease in pulmonary blood flow may cause significant problems such as serious symptoms, increases in hospitalization rate, postponement of elective heart surgery, or death. Strict infection control measures with administration of anti-RSV antibody are essential in the management of infants with heart and lung diseases.

AB - Respiratory syncytial virus (RSV) is a major causative agent of respiratory infection in infants because of its affinity for bronchial and alveolar epithelial cells. Serious and sometimes fatal RSV infection may develop in premature infants as well as infants with chronic lung disease and congenital heart disease (CHD). In infants with CHD, the addition of RSV infection to the underlying respiratory pathology resulting from increase or decrease in pulmonary blood flow may cause significant problems such as serious symptoms, increases in hospitalization rate, postponement of elective heart surgery, or death. Strict infection control measures with administration of anti-RSV antibody are essential in the management of infants with heart and lung diseases.

UR - http://www.scopus.com/inward/record.url?scp=85088429779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088429779&partnerID=8YFLogxK

U2 - 10.1007/978-981-15-1185-1_31

DO - 10.1007/978-981-15-1185-1_31

M3 - Chapter

AN - SCOPUS:85088429779

SN - 9789811511844

SP - 215

EP - 220

BT - Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension

PB - Springer Singapore

ER -

Respiratory syncytial virus infection in infants with heart and lung diseases

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this